Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Stents × Gastrointestinal × Clear all

Phase

Status

Unknown 6 Completed 4 Terminated 3 Recruiting 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Bile Duct Neoplasms 1

Interventions

Oxaliplatin 83 Capecitabine 52 Bevacizumab 52 Fluorouracil 44 Drug Therapy 39 Leucovorin 37 Gemcitabine 35 tislelizumab 33 Irinotecan 28 sintilimab 27 Cisplatin 23 lenvatinib 22 S 1 (combination) 20 Immune Checkpoint Inhibitors 20 toripalimab 17 irinotecan sucrosofate 17 apatinib 17 Surgical Procedures, Operative 17 Radiotherapy 17 HMPL-013 17 130-nm albumin-bound paclitaxel 17 Radiosurgery 16 Paclitaxel 15 Injections 15 camrelizumab 14 Folfox protocol 14 pembrolizumab 12 durvalumab 12 Immunotherapy 11 Specimen Handling 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06274879 2025-01-09

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡